Amyris Inc. (AMRS) CHIEF OPERATING OFFICER Owns Stock Worth $17605.0

Amyris Inc. (NASDAQ:AMRS) finished Tuesday with a subtraction of -$0.6 to close at $12.03, a downside of -4.75 percent. An average of 2,829,620 shares of common stock have been traded in the last five days. There was a fall of -$1.53 in the past week. The last 20 days have seen an average of 2,905,570 shares traded, while the 50-day average volume stands at 3,043,670.

AMRS stock has decreased by -9.48% in the last month. The company shares reached their 1-month lowest point of $11.73 on 10/06/21. With the stock rallying to its 52-week high on 03/15/21, shares of the company touched a low of $1.88 and a high of $23.42 in 52 weeks. In spite of this, the price is down -48.63% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Insider Transactions

35 days have passed since Amyris Inc. (AMRS) last reported insider trading activity. ALVAREZ EDUARDO, who is CHIEF OPERATING OFFICER, most recently acquired $17,605 shares at $14.86 per share on Sep 02. In this transaction, the insider spent $261,610. CHIEF LEGAL OFFICER- SECRETARY, KELSEY NICOLE, disposed of 3,483 shares at a price of $14.86 on Sep 02. The insider now owns more than $51,757 worth of shares. Prior to that, CHIEF FINANCIAL OFFICER Kieftenbeld Hermanus went on to Sale 24,380 shares at $14.86 each on Sep 02. An amount of $362,287 was transacted.

Valuation Metrics

Amyris Inc. (AMRS) has a trailing price-to-earnings (P/E) ratio of 17.00 for the broader industry and 13.02 for the sector. This means investors are optimistic about the stock’s future prospects. The stock’s beta is 1.24. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 10.49.

The quick ratio of Amyris Inc. for the three months ended September 29 was 3.10, and the current ratio was 3.70, indicating that the company is able to meet its debt obligations. On the profitability front, the trailing 12-month gross margin is 69.10% against a 5-year average of 41.7%. Amyris Inc.’s EBITDA margin for the year ending September 29 is -64.28%. Its gross profit as reported stood at $85.33 million compared to revenue of $173.14 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Amyris Inc.’s return on assets was -155.60%, compared to -156.8% over the last five years.

Earnings Surprise

The analyst consensus anticipated Amyris Inc.’s latest quarter earnings to come in at -$0.55 per share, but it turned out to be -$1.14, a -107.30% surprise. For the quarter, EBITDA amounted to -$50.95 million. Shareholders own equity worth $297.98 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Amyris Inc. (AMRS) price momentum. RSI 9-day as of the close on 05 October was 31.55%, suggesting the stock is Neutral, with historical volatility in this time frame at 67.35%.

As of today, AMRS’s price is $13.01 -11.28% or -$1.53 from its 5-day moving average. AMRS is currently trading -10.82% lower than its 20-day SMA and +3.08% higher than its 100-day SMA. However, the stock’s current price level is -17.26% below the SMA50 and +175.29% above the SMA200.

The stochastic %K and %D were 8.18% and 22.57%, respectively, and the average true range (ATR) was 0.83. With the 14-day stochastic at 9.36% and the average true range at 0.83, the RSI (14) stands at 36.87%. The stock has reached -0.97 on the 9-day MACD Oscillator while the 14-day reading was at -0.94.

Analyst Ratings

HSBC Securities launched coverage on Amyris Inc. (NASDAQ: AMRS) in its analyst report released on June 01, 2021. The firm assigned the stock a a Buy rating.The consensus rating for Amyris Inc. (AMRS) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AMRS, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 6 others rate it as a “buy”.

What is AMRS’s price target for the next 12 months?

Analysts predict a range of price targets between $19.00 and $30.00, with a median target of $21.00. Taking a look at these predictions, the average price target given by analysts for Amyris Inc. (AMRS) stock is $22.83.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam